Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,060.00
Bid: 1,872.00
Ask: 2,250.00
Change: 0.00 (0.00%)
Spread: 378.00 (20.192%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,060.00
WEIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Dec 2007 15:30

Weir Group PLC17 December 2007 TR1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Weir Group plc, The 2. Reason for notification (yes/no) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result inthe acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):______________ 3. Full name of person(s) subject to notification obligation: Baillie Gifford & Co 4. Full name of shareholder(s) (ifdifferent from 3): 5. Date of transaction (and date on which the threshold is crossed or reached if different):13 December 2007 6. Date on which issuer notified: 17 December 2007 7. Threshold(s) that is/are crossed or reached: 5% 8: Notified DetailsA: Voting rights attached to sharesClass/type Situation previous Resulting situation after the triggeringof shares to the triggering transaction transactionIf possibleuse ISIN Number Number of Number of Number of voting Percentage ofcode of voting shares rights voting rights shares rights Direct Indirect Direct IndirectOrdinary Below Below 5% 12173278 12173278 5.82 5%ShareGB0009465807 B: Financial InstrumentsResulting situation after the triggering transactionType of Expiration Exercise/ No. of voting rights that may Percentagefinancial date conversion be acquired (if the instrument of votinginstrument period/date exercised/converted) rightsN/A Total (A+B)Number of voting rights Percentage of voting rights 12173278 5.82 9. Chain of controlled undertakings through which the voting rights and /or thefinancial instruments are effectively held, if applicable:In the narrative below, the figures in ( ) indicate the amount of voting rightsand the percentage held by each controlled undertaking where relevant.Baillie Gifford & Co, a discretionary investment manager, is the parentundertaking of an investment management group.Its whollyowned direct subsidiary undertaking Baillie Gifford Overseas Limited(1744712; 0.8%) is also a discretionary investment manager.Its whollyowned direct subsidiary undertaking Baillie Gifford Life Limited(2799483; 1.3%) is a life assurance company which procures discretionaryinvestment management services from Baillie Gifford & Co in respect of its ownaccount shareholdings.Its whollyowned indirect (via Baillie Gifford Life Limited) subsidiaryundertaking Baillie Gifford & Co Limited (198600; 0.1%) is an OEIC AuthorisedCorporate Director and Unit Trust Manager which has delegated its discretionaryinvestment management role to Baillie Gifford & Co. Proxy Voting:10. Name of proxy holder: N/A11. Number of voting rights proxy holder will cease to hold:12. Date on which proxy holder will cease to hold voting rights: 13. Additional information:14 Contact name: Myra McIntyre Scott Russell15. Contact telephone number: 0131 275 2154 0131 275 2106 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jun 20245:24 pmRNSDirector/PDMR Shareholding
28th May 202412:03 pmRNSDirector/PDMR Shareholding
23rd May 20244:58 pmRNSDirector/PDMR Shareholding
15th May 20247:39 amRNSDirectorate Change
13th May 20249:54 amRNSHolding(s) in Company
25th Apr 20244:06 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Update
15th Apr 20245:21 pmRNSDirector/PDMR Shareholding
15th Apr 20244:28 pmRNSDirector/PDMR Shareholding
15th Apr 20244:19 pmRNSDirector/PDMR Shareholding
15th Apr 20244:18 pmRNSDirector/PDMR Shareholding
10th Apr 20243:18 pmRNSDirector/PDMR Shareholding
10th Apr 20242:14 pmRNSDirector/PDMR Shareholding
10th Apr 20242:11 pmRNSDirector/PDMR Shareholding
5th Apr 202411:30 amRNSHolding(s) in Company
21st Mar 202410:44 amRNS2023 Annual Report and 2024 Annual General Meeting
13th Mar 202410:31 amRNSWeir opens new foundry in China
7th Mar 202411:04 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSFull Year Results
27th Feb 20249:47 amRNSDirectorate Change
7th Feb 20248:48 amRNSHolding(s) in Company
6th Feb 20248:13 amRNSWeir achieves ‘A’ score from CDP
31st Jan 20248:07 amRNSDirectorate Change
19th Dec 202310:29 amRNSNew Board Committee and Board Changes
6th Dec 20237:00 amRNSWeir announces 2026 operating margin target of 20%
5th Dec 20233:09 pmRNSDirectorate Change
4th Dec 20231:30 pmRNSWeir study on energy in mining
23rd Nov 20237:00 amRNSWeir acquires SentianAI
14th Nov 20239:54 amRNSDirector/PDMR Shareholding
7th Nov 20239:04 amRNSDirector/PDMR Shareholding
3rd Nov 20233:51 pmRNSHolding(s) in Company
3rd Nov 20233:51 pmRNSHolding(s) in Company
1st Nov 20237:01 amRNSAppointment of Chief Financial Officer
1st Nov 20237:00 amRNSQ3 Trading Update
26th Oct 20231:55 pmRNSHolding(s) in Company
24th Oct 20238:39 amRNSDirectorate Change
2nd Oct 20237:00 amRNSCapital Markets Event – 6 December 2023
18th Aug 20235:13 pmRNSDirector/PDMR Shareholding
18th Aug 20235:00 pmRNSHolding(s) in Company
18th Aug 20232:44 pmRNSDirector/PDMR Shareholding
18th Aug 20232:30 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
31st Jul 20232:19 pmRNSTotal Voting Rights
28th Jul 20234:45 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSDirectorate change
27th Jul 20237:00 amRNSAppointment of John Heasley as Finance Director
13th Jul 202311:59 amRNSStabilisation Notice
30th Jun 20233:51 pmRNSTotal Voting Rights
14th Jun 20232:31 pmRNSHolding(s) in Company
12th Jun 20232:50 pmRNSDirector / PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.